UK markets close in 1 hour 40 minutes

Medigene AG (0QGJ.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
2.3300+0.0200 (+0.87%)
As of 08:39AM GMT. Market open.
Full screen
Previous close2.3100
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.0000 - 0.0000
52-week range
Avg. volumeN/A
Market cap572,180
Beta (5Y monthly)1.05
PE ratio (TTM)N/A
EPS (TTM)-0.4060
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Medigene Announces Strategy and Corporate Update

    Company strategy focused on developing differentiated TCR-T therapies from its proprietary “end-to-end” platform to target solid tumors with high unmet needPipeline expansion and acceleration of lead candidates with aim of advancing them into clinical developmentLead program, MDG1015, a TCR-T therapy for NY-ESO-1 combined with PD1-41BB Switch Receptor technology; at CTA /IND enabling phase, with submission planned for 2H 2024Second program, MDG10xx, TCR-T therapies for yet undisclosed targets co

  • Simply Wall St.

    Are Strong Financial Prospects The Force That Is Driving The Momentum In Medigene AG's ETR:MDG1) Stock?

    Medigene (ETR:MDG1) has had a great run on the share market with its stock up by a significant 15% over the last month...